Showing 35,162 results

EACS 2021: Abacavir sigue provocando graves problemas cardiovasculares, Viernes, 29 de octubre de 2021

October 2021

EACS 2021: Абакавир и серьезные сердечно-сосудистые осложнения, Пятница, 29 октября 2021 г.

October 2021

EACS 2021: Abacavir still causing serious cardiovascular problems, Friday 29 October 2021

October 2021
Violence

People living with HIV should be routinely asked about domestic abuse

News
28 October 2021
Side effects

Large international study finds 40% higher risk of serious cardiovascular problems in people taking abacavir since 2012

News
28 October 2021
Resistance

New cases of multi-drug resistant HIV becoming rarer in Europe

News
28 October 2021
PrEP programmes & uptake

First efficacy results from England's PrEP IMPACT Trial

News
28 October 2021

News from infohep, October 2021

October 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces European Commission Decision for Vocabria (cabotegravir) and Rekambys (rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV

Editor's pick
ViiV Healthcare
28 October 2021
HIV testing policies & guidelines

Half of speciality guidelines for medical conditions suggesting HIV don’t recommend HIV testing

News
28 October 2021
Low & theoretical transmission risks

Fact Check - Transmission of HIV by needle injuries is highly unlikely, according to a British AIDS charity

Editor's pick
Reuters
27 October 2021

Response to COVID-19 vaccines – HIV update, 27 October 2021

October 2021
Bad science & bogus treatments

Facebook, YouTube Take Down Bolsonaro Video That Said Vaccines Cause AIDS

Editor's pick
The Wire
26 October 2021
Injectable & long-acting HIV treatment

Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adults

Editor's pick
Gilead press release
26 October 2021
Access to healthcare

New study confirms MPP licences save money and lives

Editor's pick
Medicines Patent Pool
26 October 2021
Sexually transmitted infections epidemiology

Should we be worried about donovanosis, a rare, so-called 'flesh-eating' STI?

Editor's pick
The Washington Post
26 October 2021
Elimination of hepatitis C

New cases of hepatitis C have fallen among gay and bisexual men with HIV in France

News
26 October 2021
Travel

UNAIDS welcomes New Zealand’s decision to lift travel restrictions for people living with HIV

Editor's pick
UNAIDS
25 October 2021
New & experimental HIV treatments

Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
25 October 2021
Confidentiality, consent & medical ethics

HIV Scotland fined £10,000 for email data breach

Editor's pick
BBC News
25 October 2021
Coronavirus

Namibia Halts Use of Russian Sputnik Jabs After S.African HIV Fears

Editor's pick
The Moscow Times
25 October 2021
HIV testing policies & guidelines

Opt-out HIV testing is best for Black African populations in the UK

Editor's pick
Terrence Higgins Trust
25 October 2021
Coronavirus

Beta variant of COVID-19 may cause more severe illness in people with HIV

News
25 October 2021
Mental & emotional health problems

UK: Mental health services are failing to support people living with HIV, new report finds

Editor's pick
National AIDS Trust
24 October 2021